What are the current ACIP vaccine recommendations for meningococcal?
ACIP recommends adolescents age 11 or 12 years be routinely vaccinated with MenACWY and receive a booster dose at age 16 years.
What vaccines are contraindicated in SCID?
Babies with SCID should not receive rotavirus, chicken pox, mumps, rubella, measles, live virus polio, live nasal flu vaccine, or BCG vaccinations.
How often do you need a meningococcal vaccine?
Administer a booster dose of MenB vaccine 1 year after series completion and then every 2 to 3 years thereafter. For those at increased risk due to an outbreak who previously received the MenB vaccine series, CDC recommends a booster dose if a year or more has passed since primary series completion.
Which child should not receive a live virus vaccine?
Severely immunocompromised persons generally should not receive live vaccines (3). Because of the theoretical risk to the fetus, women known to be pregnant generally should not receive live, attenuated virus vaccines (4).
What is the only vaccine that is contraindicated in healthy infants under 6 months of age?
ACIP recommends that yellow fever vaccine never be given to infants aged <6 months. Infants aged 6–8 months should be vaccinated only if they must travel to areas of ongoing epidemic yellow fever and if a high level of protection against mosquito bites is not possible.
How many years is the meningococcal vaccine good for?
For children under the age of 7 years, administer a booster dose 3 years after completion of the primary series and every 5 years thereafter. For children 7 years old or older and adults, administer a booster dose 5 years after completion of the primary series and every 5 years thereafter.
Is meningococcal vaccine for life?
Available data suggest that protection from MenACWY vaccines decreases in many teens within 5 years. Getting the 16-year-old MenACWY booster dose is critical so teens have protection when they are most at risk for meningococcal disease.
When did DPT change to DTaP?
In the United States, the DPT vaccine was administered as part of the childhood vaccines recommended by the Centers for Disease Control and Prevention (CDC) until 1996 when the acellular DTaP vaccine was licensed for use.